Search Within

Alumni (GSK)

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (91)
  2. Meeting Abstract (42)
  3. Research Letter (2)
  4. Review (2)
  5. Editorial (1)
Groups
  1. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (138)
  2. Molecular Pharmacology and Chemistry Program Faculty (138)
  3. Sloan Kettering Institute Faculty (138)
  4. GSK Faculty (134)
  5. Sloan Kettering Institute Postdocs (124)
  6. Department of Medicine (100)

More Groups

People
  1. Michel Sadelain (29)
  2. Ly Vu (22)
  3. Michael Kharas (22)
  4. Ross Levine (22)
  5. Anton Dobrin (19)
  6. Neal Rosen (18)

More People

Years
  1. 2025 (2)
  2. 2024 (8)
  3. 2023 (9)
  4. 2022 (13)
  5. 2021 (15)
  6. 2020 (15)

More Years

Publications
  1. Blood (18)
  2. Cancer Research (16)
  3. Nature (9)
  4. Nature Communications (9)
  5. Cancer Discovery (8)
  6. Molecular Therapy (5)

More Publications

Publishers
  1. Nature Publishing Group (41)
  2. American Association for Cancer Research (29)
  3. American Society of Hematology (18)
  4. Cell Press (12)
  5. American Association for the Advancement of Science (4)
  6. American Chemical Society (3)

More Publishers

Results (138)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Self-assembly of carbon nanotubes and antibodies on tumours for targeted amplified delivery
    Journal Article

    Mulvey, J. J.; Villa, C. H.; McDevitt, M. R.; Escorcia, F. E.; Casey, E.; Scheinberg, D. A.
    Nature Nanotechnology (2013)

    Fulltext@MSK | Save
  • Lipid-modified aminoglycoside derivatives for in vivo siRNA delivery
    Journal Article

    Zhang, Y.; Pelet, J. M.; Heller, D. A.; Dong, Y.; Chen, D.; Gu, Z.; Joseph, B. J.; Wallas, J.; Anderson, D. G.
    Advanced Materials (2013)

    Fulltext@MSK | Save
  • ERK pathway inhibitors: How low should we go?
    Journal Article

    Nissan, M. H.; Rosen, N.; Solit, D. B.
    Cancer Discovery (2013)

    Fulltext@MSK | Save
  • Targeting the intracellular WT1 oncogene product with a therapeutic human antibody
    Journal Article

    Dao, T.; Yan, S. ; Veomett, N.; Pankov, D.; Zhou, L.; Korontsvit, T.; Scott, A.; Whitten, J.; Maslak, P.; Casey, E.; more...
    Science Translational Medicine (2013)

    Fulltext@MSK | Save
  • Biochemical evidence towards the existence of an oncogenic Hsp90 complex
    Meeting Abstract

    Rodina, A.; Moulick, K.; Ahn, J.; Zong, H. L.; Cerchietti, L.; DaGama, E. G.; Caldas-Lopes, E.; Beebe, K.; Perna, F.; Hatzi, K.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • The role of peptide deformylase in the apoptosis of c-Myc overexpressing cancers
    Meeting Abstract

    Sheth, A.; Escobar-Alvarez, S.; Ran, L. L.; Gardner, J.; Scheinberg, D. A.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90
    Meeting Abstract

    Gomes-DaGama, E. M.; Moulick, K.; Ahn, J. H.; Zong, H.; Rodina, A.; Cerchietti, L.; Lopes-Vazquez, M. E. C.; Beebe, K.; Perna, F.; Katerina, C.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • L3MBTL1: A polycomb protein at the node of crosstalk between the BMP4 and hippo signaling pathways in erythropoiesis
    Meeting Abstract

    Perna, F.; Vu, L. P.; Themeli, M.; Hoya-Arias, R. ; Liu, F.; Wang, L.; Gurvich, N.; Hricik, T.; Papapetrou, E. P.; Moore, M.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Combination therapy using JAK2 and HSP90 inhibitors increased efficacy in myelofibrosis in vivo
    Meeting Abstract

    Levine, R. L.; Koppikar, P.; Marubayashi, S.; Bhagwat, N.; Taldone, T.; Park, C. Y.; Chiosis, G.
    Blood (2012)

    Fulltext@MSK | Save
  • Heterodimeric JAK STAT activation as a mechanism of persistence to JAK2 inhibitor therapy
    Journal Article

    Koppikar, P.; Bhagwat, N.; Kilpivaara, O.; Manshouri, T.; Adli, M.; Hricik, T.; Liu, F.; Saunders, L. M.; Mullally, A.; Abdel-Wahab, O.; more...
    Nature (2012)

    Fulltext@MSK | Save